Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000009

PRESIDENT AND COO sold 22,500 shares at $417.50 ($9,393,671)

  • PRESIDENT AND COO acquired 22,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-27 Exercise or conversion : show line 1 in the form 10b5-1 +14,625 $135.42 $1,980,518 14,625 I
2025-10-27 Sale : show line 2 in the form 10b5-1 −14,625 $417.50 $6,105,886 0 I
2025-10-27 Exercise or conversion : show line 3 in the form 10b5-1 +6,125 $146.03 $894,434 6,125 I
2025-10-27 Exercise or conversion : show line 4 in the form 10b5-1 +1,750 $146.03 $255,553 7,875 I
2025-10-27 Sale : show line 5 in the form 10b5-1 −7,875 $417.50 $3,287,785 130 I
Open-market sales · 22,500 sh · avg $417.50 · $9,393,671

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-10-27 Exercise or conversion : show line 6 in the form 10b5-1 Stock Options −14,625 $135.42 2026-03-15 14,625 55,875 I
2025-10-27 Exercise or conversion : show line 7 in the form 10b5-1 Stock Options −6,125 $146.03 2026-03-15 6,125 18,375 I
2025-10-27 Exercise or conversion : show line 8 in the form 10b5-1 Stock Options −1,750 $146.03 2027-03-15 1,750 0 I
Loading xslF345X05/primarydocument.xml…